Actively Recruiting
Auto Stem Cell Transplant for Lymphoma Patients
Led by Masonic Cancer Center, University of Minnesota · Updated on 2025-11-04
150
Participants Needed
1
Research Sites
523 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a phase II study of autologous transplant for patients with Hodgkin (HL) and non-Hodgkin lymphomas (NHL) including those who are HIV positive.
CONDITIONS
Official Title
Auto Stem Cell Transplant for Lymphoma Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of chemo-sensitive non-Hodgkin lymphoma (NHL) or Hodgkin lymphoma (HL) confirmed by histology
- NHL patients in partial or complete remission after cell therapy
- Specific lymphoma subtypes with defined remission or risk status as detailed in protocol
- HIV positive patients under active HIV care with controlled viral load and CD4+ count 6/bcl
- Karnofsky Performance Status 80% (or Lansky Play Score 80 for patients under 16 years)
- Adequate organ function including hematologic, renal, hepatic, cardiac, pulmonary, and CNS criteria
- At least 4 weeks since last chemotherapy (6 weeks for nitrosoureas)
- Agreement to use birth control for women of childbearing potential and sexually active males
- Voluntary written consent
You will not qualify if you...
- Pregnancy or breastfeeding
- Eligibility for higher priority transplant protocols
- Chemotherapy resistant disease (no partial response after up to 3 chemotherapy cycles)
- Active unrelated infections
- Serious uncontrolled organ dysfunction not related to lymphoma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
Research Team
T
Timothy Krepski
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here